Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03MZU
|
|||
| Former ID |
DIB006143
|
|||
| Drug Name |
AHCQ
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 2 | [1] | |
| Company |
APT
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Aradigm and APT Pharmaceuticals Initiate Phase 2 Clinical Program of Novel Treatment for Asthma | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.